Cargando…
Using a Panel of Immunomarkers to Define Homologies in Mammalian Brains
Brain mapping has relied on a small number of routine chemical stains for many decades. The advent of immunomarkers has had a major impact on the ability to define homologous nuclei from one species to another. The first atlas to present a panel of immunomarkers was that of Paxinos et al. (1999a,b)...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831708/ https://www.ncbi.nlm.nih.gov/pubmed/20204155 http://dx.doi.org/10.3389/neuro.09.013.2010 |
_version_ | 1782178263618027520 |
---|---|
author | Watson, Charles R. Paxinos, George Tokuno, Hironobu |
author_facet | Watson, Charles R. Paxinos, George Tokuno, Hironobu |
author_sort | Watson, Charles R. |
collection | PubMed |
description | Brain mapping has relied on a small number of routine chemical stains for many decades. The advent of immunomarkers has had a major impact on the ability to define homologous nuclei from one species to another. The first atlas to present a panel of immunomarkers was that of Paxinos et al. (1999a,b) in the adult rat brain. The markers used were parvalbumin, calbindin, calretinin, SMI32, tyrosine hydroxylase, and NADPH diaphorase (plus nissl and acetylcholinesterase). The ‘signature’ of a nucleus of interest in a new species can be tested against the findings in the rat. Since the pattern of immunomarkers seems to be conserved in mammalian evolution, such extrapolations can be made with reasonable confidence. A marmoset brain stained with a comprehensive set of immunomarkers has recently been published on the internet (Tokuno et al., 2009) and we are in the process of defining nuclear homologies in this brain by comparison with the same markers in the rat. In this article, we present an example (mapping the amygdala in the marmoset) which demonstrates the application of this immunomarker panel in defining homologies. The technique is particularly valuable in situations where little data on hodology or electrophysiology are available. |
format | Text |
id | pubmed-2831708 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Frontiers Research Foundation |
record_format | MEDLINE/PubMed |
spelling | pubmed-28317082010-03-04 Using a Panel of Immunomarkers to Define Homologies in Mammalian Brains Watson, Charles R. Paxinos, George Tokuno, Hironobu Front Hum Neurosci Neuroscience Brain mapping has relied on a small number of routine chemical stains for many decades. The advent of immunomarkers has had a major impact on the ability to define homologous nuclei from one species to another. The first atlas to present a panel of immunomarkers was that of Paxinos et al. (1999a,b) in the adult rat brain. The markers used were parvalbumin, calbindin, calretinin, SMI32, tyrosine hydroxylase, and NADPH diaphorase (plus nissl and acetylcholinesterase). The ‘signature’ of a nucleus of interest in a new species can be tested against the findings in the rat. Since the pattern of immunomarkers seems to be conserved in mammalian evolution, such extrapolations can be made with reasonable confidence. A marmoset brain stained with a comprehensive set of immunomarkers has recently been published on the internet (Tokuno et al., 2009) and we are in the process of defining nuclear homologies in this brain by comparison with the same markers in the rat. In this article, we present an example (mapping the amygdala in the marmoset) which demonstrates the application of this immunomarker panel in defining homologies. The technique is particularly valuable in situations where little data on hodology or electrophysiology are available. Frontiers Research Foundation 2010-02-26 /pmc/articles/PMC2831708/ /pubmed/20204155 http://dx.doi.org/10.3389/neuro.09.013.2010 Text en Copyright © 2010 Watson, Paxinos and Tokuno. http://www.frontiersin.org/licenseagreement This is an open-access article subject to an exclusive license agreement between the authors and the Frontiers Research Foundation, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are credited. |
spellingShingle | Neuroscience Watson, Charles R. Paxinos, George Tokuno, Hironobu Using a Panel of Immunomarkers to Define Homologies in Mammalian Brains |
title | Using a Panel of Immunomarkers to Define Homologies in Mammalian Brains |
title_full | Using a Panel of Immunomarkers to Define Homologies in Mammalian Brains |
title_fullStr | Using a Panel of Immunomarkers to Define Homologies in Mammalian Brains |
title_full_unstemmed | Using a Panel of Immunomarkers to Define Homologies in Mammalian Brains |
title_short | Using a Panel of Immunomarkers to Define Homologies in Mammalian Brains |
title_sort | using a panel of immunomarkers to define homologies in mammalian brains |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831708/ https://www.ncbi.nlm.nih.gov/pubmed/20204155 http://dx.doi.org/10.3389/neuro.09.013.2010 |
work_keys_str_mv | AT watsoncharlesr usingapanelofimmunomarkerstodefinehomologiesinmammalianbrains AT paxinosgeorge usingapanelofimmunomarkerstodefinehomologiesinmammalianbrains AT tokunohironobu usingapanelofimmunomarkerstodefinehomologiesinmammalianbrains |